TESAMORELIN, 10 mg

Tesamorelin is a synthetic analog of growth hormone–releasing hormone (GHRH), engineered with a small structural modification to enhance stability and receptor affinity. Research highlights its ability to stimulate a pulsatile, physiologic‑style release of growth hormone, making it a key peptide of interest in studies focused on metabolism, visceral fat regulation, and growth‑hormone axis signaling.

Key Research Areas

• Visceral fat metabolism — Studies consistently show Tesamorelin’s ability to reduce visceral adipose tissue while minimally affecting subcutaneous fat, making it a central peptide in metabolic research.
• Growth hormone axis regulation — Used to study endogenous GH secretion patterns and IGF‑1–related pathways in controlled experimental settings.
• Metabolic and hepatic signaling — Research explores its influence on glucose handling, lipid metabolism, and hepatic gene expression.
• Body‑composition modeling — Investigated for its effects on muscle preservation, recovery, and metabolic health markers.

⚠️ For Research Use Only
This product is not for human or veterinary use. It is intended strictly for laboratory research. Any mention of effects is based on scientific literature and does not imply approval by Health Canada or any regulatory agency